[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"After Hours Midcaps ($2-20B) - Oct XX Gainers Losers $JBHT +12% $BITF -XXX% $AUGO +5.2% $SLNO -XXX% $CHDN +4.8% $URBN -X% $KNX +4.1% $EOSE -XXX% $PPTA +4% $FOLD -XXX% $BANR +3.8% $CYTK -XXX% $MVST +3.5% $OCUL -XXX% $GRND +3.4% $ZION -XXX% $CORT +3.3% $REXR -XXX% $RUSHA +3.2% $HIMS -XXX% $CRML +3.1% $SITM -X% $VSEC +2.8% $WWD -X% $DLO +2.7% $AAON -X% $WFRD +2.7% $ALRM -X% $BLTE +2.6% $SGRY -2%"
X Link @MarketCap_Live 2025-10-15T23:02Z XXX followers, 1357 engagements
"Monster in the making $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"
X Link @mariostario2019 2025-10-14T16:27Z XX followers, XXX engagements
"$FOLD: Amicus Therapeutics is on the verge of a profitability breakthrough fueled by its rapid revenue growth and two high-impact rare disease franchises. The companys transition from cash-burning developer to cash-generating leader could unlock a re-rating for investors. Galafold anchors stability while Pombiliti + Opfolda accelerates expansion into new markets. Managements disciplined pipeline bets like DMX-200 add upside not yet priced in. Will Amicus deliver on its promise of sustained profitability and reward shareholders"
X Link @SentinelFlash 2025-10-13T22:10Z XXX followers, XXX engagements
"Themes Sectors and Sub Markets Gold Miners #2 Leaders $SSRM $AU $GFI $CDE $KGC Setting Up $KGC $SA $B $PAAS $AGI Biotechnology #3 Leaders $QURE $MTSR $CDTX $COGT $IONS Setting Up $ARWR $ROIV $FOLD $VERA $EXEL Silver Miners #5 Leaders $SSRM $CDE $MUX $HL $BVN Setting Up $PAAS"
X Link @TradersLab_ 2025-10-12T01:17Z 3437 followers, 5397 engagements